Key Interactions Between Anastrozole and Herbal Supplements
Understanding Anastrozole Interactions with Herbal Supplements: A Guide for Safe Usage
Disclaimer: The information provided in this article is for educational purposes only and does not constitute medical advice. Herbal supplements can significantly impact the efficacy of medications like Anastrozole. Always consult with your oncologist or a licensed medical professional before introducing any new supplement into your regimen.
Anastrozole (brand name Arimidex) is a non‑steroidal aromatase inhibitor used as adjuvant treatment in post‑menopausal women with estrogen‑receptor positive (ER+) breast cancer. It reduces estrogen biosynthesis by inhibiting the aromatase enzyme that converts androgens to estrogens, thereby limiting stimulation of ER‑dependent tumour growth.
Metabolic Pathway: Anastrozole is metabolised primarily in the liver by cytochrome‐P450 (CYP) enzymes. Pharmacogenomics research notes that CYP3A4 is the major metabolic pathway with contributions from CYP2B6, CYP2D6, CYP2C8 and UGT1A4. Because it is metabolised by CYP3A4, supplements that induce or inhibit this enzyme or act on P‑glycoprotein (P-gp) may alter the drug’s concentration. Moreover, any product with estrogenic activity could counteract anastrozole’s mechanism. 🧪
Overview of Herbal‑Drug Interactions
Formulator Note: When sourcing ingredients for oncology-support supplements, ensure extracts are verified non-estrogenic to maintain formula safety and avoid therapeutic interference. ⚠️
Types of Interactions
- Phytoestrogenic herbs: These may increase circulating estrogens. Examples: red clover, soy isoflavones, flaxseed, dong quai, ginseng, licorice, kudzu and maca.
- CYP450 modulators: Herbs that induce CYP3A4 (St. John’s wort) decrease drug levels, while inhibitors (grapefruit juice, ginseng, echinacea) increase toxicity.
- P‑glycoprotein (P-gp) modulators: P‑gp is an efflux transporter that influences oral drug absorption. Herbs like St. John’s wort can induce P‑gp, which can significantly reduce drug bioavailability.
- Herbs increasing bleeding risk: Some herbs have antiplatelet or anticoagulant properties. Combined with Anastrozole, these may increase the risk of bruising or hemorrhage. Examples include turmeric, ginseng, ginkgo biloba, garlic, and valerian.
- Hepatotoxicity: Since Anastrozole is metabolised in the liver, hepatotoxic herbs (e.g., high‑dose green tea extract, kava) may compound hepatic stress. The Oncology Nursing Society specifically notes that green tea extract may increase anastrozole hepatotoxicity. ⚠️
Evidence for Specific Herbs and Supplements
1. St. John’s Wort (Hypericum perforatum)
St. John’s wort is a popular herbal antidepressant. It strongly induces CYP3A4 and P‑gp, leading to reduced plasma levels of many drugs. It may similarly reduce anastrozole concentration, lowering its clinical efficacy. Because enzyme induction persists for weeks after discontinuation, patients should not take St. John’s wort without oncologist approval.
Formulator Alert: For brands developing mood-support alternatives for oncology patients, consider non-inducing botanicals that do not interfere with the CYP3A4 pathway to ensure patient safety. 🧪
2. Ginseng (Panax ginseng and other species)
Ginseng is used for energy but can be problematic in hormone‑sensitive cancers. Panax ginseng contains ginsenosides that exhibit weak estrogenic activity; studies suggest they may stimulate ER‑positive tumour cells. Ginseng also inhibits or induces CYP3A4 and CYP2C9, and its bleeding risk is a concern, particularly when combined with anticoagulants. Patients on anastrozole should avoid ginseng products.
3. Red Clover, Soy Isoflavones, Flaxseed and Other Phytoestrogens
Red clover (Trifolium pratense) and soy contain isoflavones (genistein, daidzein) that act as selective estrogen receptor modulators. High doses of soy isoflavones can stimulate ER‑positive breast cancer cells, potentially counteracting the therapeutic goal of Anastrozole. A wide range of supplements—including flaxseed, guggul, kudzu, licorice, maca, and red raspberry leaf—contain plant estrogens that should be avoided during aromatase inhibitor therapy.
Formulator Note: When sourcing botanical ingredients for women's health products, ensure extracts are verified non-estrogenic through standardized testing to maintain safety for oncology patients. 🧪
4. Black Cohosh (Actaea racemosa)
Black cohosh is frequently used for menopausal symptoms, but case reports of hepatotoxicity and concerns over CYP450 activity modulation make it a risk. While its estrogenic activity is debated, it is listed among herbs that can alter drug metabolism and increase bleeding risk when combined with anticoagulants. Most clinical handouts advise avoiding black cohosh during Anastrozole therapy. ⚠️
5. Dong quai (Angelica sinensis)
Used in traditional Chinese medicine, Dong quai contains coumarins and ferulic acid with potential estrogenic effects. It is also known to potentiate anticoagulants, significantly increasing bleeding risk. Because it may stimulate estrogen receptors, it is best avoided for patients with ER+ cancer.
6. Ginkgo Biloba
Promoted for cognitive health, Ginkgo is a weak CYP3A4 inhibitor and can also inhibit CYP2C9. Combined with Anastrozole, it could increase drug concentrations or exacerbate bleeding risk. Given the lack of proven benefit for cancer patients, its use is generally discouraged.
7. Licorice (Glycyrrhiza species)
Licorice contains glycyrrhizin, which possesses weak estrogenic activity. It may also raise blood pressure and cause hypokalemia. Due to these phytoestrogenic effects, licorice supplements (including DGL) should be avoided by patients on Anastrozole. 🍬
8. Milk Thistle (Silybum marianum)
Silymarin, the active complex in milk thistle, can inhibit CYP3A4 and other hepatic enzymes. While clinical data are limited, some evidence suggests it can alter the pharmacokinetics of drugs metabolised by the liver. Additionally, milk thistle seeds may contain phytoestrogens, leading many clinicians to recommend abstaining from high‑dose supplements.
9. Turmeric/Curcumin (Curcuma longa)
Curcumin has anti‑inflammatory properties but also exhibits significant antiplatelet activity. Clinical guidance suggests that curcumin should not be taken with Anastrozole because it may increase bleeding risk and potentially lead to gallbladder obstruction.
Formulator Alert: For standardized inflammatory support without the antiplatelet risks associated with high-dose turmeric, consider formulating with Boswellia Serrata. 🧪
10. Valerian (Valeriana officinalis) and Other Sedatives
Valerian is commonly used for insomnia but may inhibit CYP3A4 and enhance the sedative effects of other medications. Other sedative herbs, like kava, have been linked to severe hepatotoxicity. Unless supervised by a healthcare provider, these should be avoided during endocrine therapy to prevent metabolic interference.
11. Green Tea (Camellia sinensis)
While brewed tea is generally safe, concentrated green tea extracts (EGCG) can induce or inhibit CYP enzymes and are associated with liver stress. The Oncology Nursing Society warns that green tea extract may increase the hepatotoxicity of anastrozole. Weight-loss products containing high doses of green tea are a particular concern. 🍵
12. Garlic, Ginger and Other Bleeding‑Risk Herbs
In concentrated supplement form, these culinary herbs possess antiplatelet properties and may inhibit CYP enzymes. High doses of garlic, ginseng, ginkgo, and ginger can exacerbate bleeding or bruising when combined with chemotherapy or aromatase inhibitors. At culinary doses they are safe, but for standardized formulations, explore our Ginger Collection.
Other Vitamins and Dietary Supplements
While standard multivitamins are generally safe, doctors recommend avoiding supplements containing phytoestrogens such as red clover, wild yam and soy isoflavones because they might oppose the drug’s estrogen‑lowering effect. High‑dose antioxidants or “bioidentical hormone” products should also be avoided unless specifically recommended by a clinician. 💊
Practical Guidance for Patients and Clinicians
- Communicate openly about supplements: Patients should provide a complete list of all herbal products to their healthcare team to check for metabolic interference. 🗣️
- Avoid high‑dose phytoestrogenic herbs: Concentrated extracts of red clover, soy, flaxseed oil, and maca can counteract the estrogen-lowering effect of Anastrozole.
- Beware of CYP3A4 and P‑gp modulators: Avoid St. John’s wort, ginseng, and grapefruit juice (a potent CYP3A4 inhibitor) to prevent altered drug concentrations. 🧪
- Limit herbs that increase bleeding or hepatotoxicity: Turmeric, ginger, and garlic supplements may increase bleeding risk, while kava can cause liver injury.
- Use reputable resources: Consult evidence‑based databases like the Memorial Sloan Kettering About Herbs database. 📚
Conclusion: Navigating Anastrozole–Herbal Interactions
Anastrozole is a cornerstone of endocrine therapy, but its efficacy relies on maintaining specific CYP3A4 metabolic pathways and low estrogen levels. Herbal supplements with estrogenic activity or those that modulate drug-metabolising enzymes can interfere with safety and treatment success. Following the precautionary principle, patients should avoid high-dose herbal supplements during therapy unless supervised by an oncologist. 🛡️
Frequently Asked Questions
Q: Can I take Turmeric (Curcumin) with Anastrozole?
A: Using Turmeric as a culinary spice in food is generally considered safe. However, high-dose Curcumin supplements should be avoided as they have antiplatelet effects that may increase bleeding risk and may interfere with drug-metabolizing enzymes.
Q: Is Vitamin D safe to take with Anastrozole?
A: Yes. Many oncologists recommend Vitamin D and Calcium supplements to combat bone density loss (osteoporosis), which is a common side effect of aromatase inhibitors. Always confirm the dosage with your provider.
Q: Can I take Magnesium for joint pain while on this medication?
A: Magnesium is typically safe and often helps with muscle cramps and joint stiffness associated with Anastrozole. It does not interact with the CYP3A4 pathway.
Q: How long should I wait after stopping St. John's Wort before starting Anastrozole?
A: St. John's Wort induces liver enzymes for a prolonged period. Most clinical guidelines suggest waiting at least 14 days after your last dose before starting therapy to ensure your metabolism has returned to baseline.
Q: Can I use CBD or Hemp oil while taking Anastrozole?
A: There is evidence that CBD can inhibit certain CYP450 enzymes (like CYP3A4) responsible for metabolizing Anastrozole. High-dose CBD could potentially alter the concentration of the medication in your system.
Q: Is it safe to drink Green Tea while on this medication?
A: Brewed tea is generally safe, but you must avoid concentrated Green Tea extracts (EGCG). These concentrated forms can cause hepatotoxicity and place significant stress on the liver where the drug is processed.
Q: Does Melatonin interact with Anastrozole?
A: Research suggests there is no direct contraindication. It is often used under medical supervision to manage the sleep-wake cycle without interfering with aromatase inhibition.
Free Professional Resource
Download our 2026 Botanical Safety Matrix—a quick reference guide for formulators and practitioners on herb-drug interactions in oncology.
Get the Free Safety ChecklistBibliography
Rutherford DV, et al. Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226. Pharmacogenomics. 2023;24(12):665–673. PMC.
Hartmann KE, et al. Precautions for Patients Taking Aromatase Inhibitors. Journal of Advanced Practitioner in Oncology. 2023.
National Health Service (NHS). Taking anastrozole with other medicines. Updated 2024. NHS.uk.
Oncology Nursing Society. Herb–drug interactions: guidance for oncology nurses. October 2024. ONS Voice.
Siegel RL, et al. Are Your Patients Taking Herbs That May Interact With Their Cancer Drugs? Oncology Nursing Society. 2017.
Jameson JL, et al. Oral antineoplastic agent interactions with medicinal plants and food. Journal of Cancer Research & Clinical Oncology. 2016.
Sweeney C, et al. Supplement interactions with chemotherapy. US Pharmacist. 2019.
Pertz S, et al. UW Integrative Health: Supplement interactions and estrogen‑receptor positive breast cancer. 2020.
Massachusetts General Hospital Cancer Center. Aromatase Inhibitors patient teaching handout. March 2024.
CancerChoices (Healwell). Turmeric and curcumin safety. Updated 2025.
Medical News Today. Interactions and contraindications for Arimidex. April 2025.
Healthline. Anastrozole side effects and interactions. 2025.
Bezzy Breast Cancer. Herbal supplements to avoid on anastrozole. 2025.